Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Endocrinology, Diabetes and Metabolism is Scopus-indexed (Q2, CiteScore 5.1), WoS ESCI, DOAJ. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 2398-9238Verify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 101 / 250 | 59th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 5.1.
Endocrinology, Diabetes and Metabolism is Q2 in Endocrinology, Diabetes and Metabolism (rank 101 of 250), by CiteScore 2025.
Endocrinology, Diabetes and Metabolism is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.992, quartile Q2, with an H-index of 27.
The publisher lists an article processing charge of about US$3,280 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Endocrinology, Diabetes and Metabolism is published by Wiley-Blackwell Publishing Ltd. Its ISSN is 2398-9238.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Endocrinology, Diabetes and Metabolism has an h-index of 39 and a 2-year mean of 2.73 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q2. On 2-year citations it ranks #95 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Endocrinology, Diabetes and Metabolism published 132 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from Iran (19%), Pakistan (12.4%) and United States (9.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.